FNMA(FNMA)
FNMA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $29.26B | $30.19B | $32.03B |
| Low | $29.21B | $29.69B | $32.02B |
| High | $29.31B | $30.53B | $32.05B |
| EBITDA Avg | $27.53B | $28.40B | $30.14B |
| Low | $27.48B | $27.93B | $30.13B |
| High | $27.58B | $28.73B | $30.15B |
| EBIT Avg | $27.53B | $28.40B | $30.14B |
| Low | $27.48B | $27.93B | $30.13B |
| High | $27.58B | $28.73B | $30.15B |
| Net Income Avg | $14.94B | $15.42B | — |
| Low | $14.74B | $14.97B | — |
| High | $15.14B | $15.88B | — |
| EPS Avg | $2.54 | $2.62 | — |
| Low | $2.50 | $2.54 | — |
| High | $2.57 | $2.70 | — |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $7.28B | $7.34B | $7.42B | $7.46B | $7.51B | $7.58B |
| Low | $7.26B | $7.23B | $7.31B | $7.35B | $7.39B | $7.46B |
| High | $7.29B | $7.40B | $7.48B | $7.52B | $7.57B | $7.64B |
| EBITDA Avg | $6.85B | $6.91B | $6.99B | $7.02B | $7.06B | $7.13B |
| Low | $6.83B | $6.80B | $6.88B | $6.91B | $6.95B | $7.02B |
| High | $6.85B | $6.96B | $7.04B | $7.08B | $7.12B | $7.19B |
| EBIT Avg | $6.85B | $6.91B | $6.99B | $7.02B | $7.06B | $7.13B |
| Low | $6.83B | $6.80B | $6.88B | $6.91B | $6.95B | $7.02B |
| High | $6.85B | $6.96B | $7.04B | $7.08B | $7.12B | $7.19B |
| Net Income Avg | $3.73B | $3.80B | $3.89B | $3.91B | $3.89B | $3.91B |
| Low | $3.67B | $3.72B | $3.81B | $3.83B | $3.81B | $3.83B |
| High | $3.79B | $3.84B | $3.93B | $3.95B | $3.93B | $3.95B |
| EPS Avg | $0.63 | $0.65 | $0.66 | $0.66 | $0.66 | $0.66 |
| Low | $0.62 | $0.63 | $0.65 | $0.65 | $0.65 | $0.65 |
| High | $0.64 | $0.65 | $0.67 | $0.67 | $0.67 | $0.67 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |